Fang Zhou, MSc

Takeda Pharmaceutical Company, Shanghai, China, China

Poster(s):

• P2773 - Effectiveness and Safety of Vonoprazan Treatment on Symptoms in Elderly Patients With Reflux Esophagitis in China: Post Hoc Analysis of the VIEW Study
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT

• P2774 - Impact of Patient and Disease Characteristics on the Effectiveness of Vonoprazan in Chinese Patients With Reflux Esophagitis: Post-Hoc Analysis of the Multicenter Prospective VIEW Study
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT

• P2775 - Baseline Characteristics of Patients With Reflux Esophagitis Receiving Vonoprazan Treatment in China: Post Hoc Analysis of the VIEW Real-World Study
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT